Fondaparinux sodium

磺达肝癸钠;磺达肝癸钠含量 USP标准品;磺达肝癸钠鉴定 USP标准品;磺达肝素钠;磺达肝素钠鉴定;磺达肝素(癸)钠;FONDAPARINUX SODIUM 磺达肝癸钠;磺达肝癸钠 40MG;黄达肝葵那杂质

Fondaparinux sodium

Fondaparinux sodium;decasodium (2R,3S,4S,5R,6R)-3-[(2R,3R,4R,6R)-5-[(2R,3R,4S,5S,6S)-6-carboxylato-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-oxan-2-yl]oxy-3-(sulfonatoamino)-4-sulfonatooxy-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxy-oxane-2-carboxylate;FONDAPARINUX SODIUM SALT;Fondaparin sodium;SR-90107A;Fondaparinux sodium solution;Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-β-D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-2-O-sulfo-α-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-α-D-glucopyranoside 6-(hydrogen sulfate) sodium salt;a-D-Glucopyranoside, methylO-2-deoxy-6-O-sulfo-2-(sulfoamino)-a-D-glucopyranosyl-(1®4)-O-b-D-glucopyranuronosyl-(1®4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-a-D-glucopyranosyl-(1®4)-O-2-O-sulfo-a-L-idopyranuronosyl-(1®4)-2-deoxy-2-(sulfoamino)-,6-(hydrogen sulfate), decasodium salt (9CI);Arixtra;IC 85158;IC 851589;Org 31540;SR 90107A;Xantidar;D01844;Arixtra (tn);Fondaparinux sodium N-4;Fondaparinux (sodium salt);Fondaparinux sodiuM(D01844);Fondaparinux and intermediates;Fondaparinux sodium, >=98%;Quixidar;X0Q6N9USOZ;fondaparinux-sodium;Fondaparinux sodium [USAN:INN:BAN];Fondaparinux sodium (JAN/USAN/INN);alpha-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-al;Fondaparinux sodium for assay;Fondaparinux sodium identification;Methly O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-a

114870-03-0

C₃₁H₄₃N₃Na₁₀O₄₉S₈

1728.08